Stayble Therapeutics (private company)

Stayble is developing an injection-based treatment against chronic back pain that will effectively remove the pain and the need for spinal fusion.

The chronic back pain is a condition that affects about 24 million people in the United States and Europe and is estimated to cost up to $ 40 billion annually in the US alone. Today there is no effective treatment other than fusion surgery for those patients who do not improve out painkillers and physiotherapy.

With Stayble's treatment only a single injection is needed as the goal is for the patient to be pain free within a few weeks after the injection.

Stayble’s treatment offers the patient a completely new way to treat its chronic low back pain and will drastically change the way surgeons treat cLBP.